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Ideas crystallized on immunoglobulin 
superfamily-integrin interactions 
Interactions between immunoglobulin superfamily (IgSF) members and integrins are 
central to lymphocyte homing, leukocyte emigration into tissues at inflammatory sites, and 
in cell-cell interactions that lead to immune responses. Recent X-ray crystal structures 
reveal that the interaction of a divalent cation found in the integrin structure with an 
acidic residue from the IgSF partner may be important in binding. 
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Communication between cells is particularly important 
in the immune system, in which cells are required to 
locate and migrate to sites of inflammation, and are acti- 
vated by direct interactions with other cells.The cell-cell 
interactions important for these processes are mediated 
by cell-surface molecules that are collectively termed 
adhesion molecules, which can be broadly grouped into 
distinct families based on structural similarities. A large 
number of these molecules fall into the integrin and 
immunoglobulin superfamilies [1,2]. Both integrins and 
immunoglobulin superfamily (IgSF) members can bind 
to a variety of structurally diverse targets, but in many 
important cell-cell interactions IgSF members interact 
with members of the integrin family (Fig. 1). Because of 
the strong similarities within families, it is likely that the 
interaction surfaces for different integrin-IgSF member 
pairs have common features. Detailed mutagenesis 
studies and some new structural information, including 
the first structure of an integrin domain, have recently 
revealed some of the features that may be generally 
important for interactions between molecules of these 
two families. 
The overall architecture of IgSF molecules has been 
known for some time; they are composed of several 
copies of a fold that has become classic, the Ig domain. 
Each Ig domain is -100-110 amino acids long, and 
forms a sandwich of two B sheets, consisting of anti- 
parallel B strands of 5-10 amino acids. There is a con- 
served disulfide bond between the two B sheets in the 
great majority of domains. All IgSF members that bind 
integrins contain an integrin-binding site in their first 
or amino-terminal Ig domain (Dl, Fig. 1). VCAM-1 
contains an additional integrin-binding site in its fourth 
Ig domain, which is highly homologous to its first 
domain; both sites bind to VLA-4. The ICAM- mol- 
ecule binds two different integrins, LFA-1 through Dl 
and Mac-l through D3. 
The integrin family glycoproteins consist of non- 
covalently bound olB heterodimers; they require bound 
divalent cations to function. Two of the integrins that 
bind to IgSF members, Mac-l and LFA-1, have a 
180-200 amino-acid insertion in their OL subunit, known 
as the I domain, which for these integrins is thought to 
be important for their interaction with their IgSF 
partner. It is interesting, though puzzling, that the struc- 
tural motifs on ICAM-1, ICAM- andVCAM-1 identi- 
fied by mutagenesis as being important for binding to 
integrins are all very similar, despite the fact that their 
integrin targets are structurally different; the amino- 
terminal domains of both ICAM- and ICAM- bind to 
an I-domain-containing integrin, LFA-1, whereas 
VCAM-1 binds to two integrins that lack an I domain, 
VLA-4 and 014B,.Thus,VCAM-l must target a different 
integrin domain from ICAM- and ICAM-3, yet the 
structural motif important for binding appears to be 
conserved in the three IgSF members. 
The crystallization of domains 1 and 2 of VCAM-1 
[3,4], along with extensive mutagenesis of VCAM-1 and 
ICAMs [5-lo] has provided a detailed understanding of 
the integrin-binding sites found in these molecules. 
Mutagenesis of domain 1 of VCAM-1 has identified 
numerous residues important for VCAM-1 function, 
with mutations centered around Asp40 completely abol- 
ishing functionThese amino acid substitutions map to or 
near the protruding C-D loop identified in the crystal 
structure (Fig. 2).The three-dimensional structure of the 
C-D loop is important in integrin binding, as a cyclic 
peptide (Cys-Gln-Ile-Asp-Ser-Pro-Cys) which closely 
mimics the loop was found to inhibit adhesion of 
VLA-4-bearing cells to purifiedVCAM-1, while a linear 
peptide of identical sequence was inactive [4]. Other 
residues located outside the C-D loop, especially those 
on the E-F loop of domain 1, are also thought to be 
involved in ligand binding. These residues may interact 
directly with ligand, or may stabilize the C-D loop 
through the extensive network of hydrogen bonding 
between the C-D and E-F loops. 
Detailed mutagenesis of the fourth Ig domain of V CAM-l 
[5,6], and the amino-terminal Ig domains of ICAM- and 
ICAlV-3 [g-10] have shown that the critical residues 
involved in integrin binding are also located in the C-D 
loop. For the binding of VCAM-1 to VLA-4, the key 
residue in both domains 1 and 4 of VCAM-1 is an aspar- 
tate, whereas for the amino-terminal domains of ICAM- 
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Fig. 1. Schematic diagram of integrin 
and @SF members that form adhesion 
ligand pairs. These interactions are 
important in several biological 
processes. For example, the adhesion of 
neutrophiis to vascular endothelium, an 
early step in the process of their migra- 
tion through the wall of the blood vessel 
to the site of an infection, is mediated by 
LFA-1 and Mac-l binding to ICAM-1, 
while VLA-4 interactions with VCAM-1 
are important in the homing of mature, 
activated T cells to tissues. For reviews 
on the biological functions of these 
interactions, see [1,2]. Arrows indicate 
the integrin-IgSF interactions that have 
been demonstrated. The overall size and 
shape of the integrins and IgSF members 
are shown to scale, based on electron 
microscopy (bar 10 nm). It is as yet 
unclear how the I domain may fold up 
with the rest of the globular head. 
Divalent cation binding sites are symbol- 
ized by ‘+‘. Disulfide-bonded cysteines 
are denoted in the IgSF members by ‘SS’. 
In the integrin a-subunits SS denotes a 
disulphide bond that bridges a cleavage 
site; in the p-subunits it designates a 
cysteine-rich region. The serinekhreo- 
nine-rich mucin domain of MAdCAM-1, 
an IgSF member which guides lympho- 
cyte entry into mucosal lymphoid tissue 
such as the gut is also indicated. 
and ICAM- this residue is a glutamic acid. Sequence 
analysis of the C-D loops in Ig domains involved in inte- 
grin binding reveals strong similarities, which are well con- 
served across species. From these data, a tentative consensus 
sequence on the IgSF molecule of Ile/Leu-Asp/Glu- 
Ser/Thr-Pro&$-Leu(Xaa) for integrin-IgSF interactions 
has been proposed (Xaa indicates that alternative residues 
are used in some cases) [5]. 
Although the integrin-binding sites on the IgSF 
members have been extensively investigated, the corre- 
sponding regions on the integrins have only recently 
been defined. The (Y subunits of integrins that interact 
with IgSF members (a4, (xL and a”) contain three puta- 
tive cation-binding repeats in the globular head region 
(Fig. 1); 01~ and aM also contain an I domain at their 
amino terminus.The I domain (sometimes also referred 
to as an A domain) is found in one or more copies in a 
wide range of proteins involved in cell-cell, cell-matrix, 
and matrix-matrix interactions. 
The recent determination of the crystal structure of the 
Mac-l I domain [ll] has offered insight into how the 
C-D loop, and more specifically the key acidic aspartate 
or glutamate residue, is involved in integrin binding. The 
I domain is an open sheet structure with alternating 
amphipathic 01 helices and central hydrophobic p strands, 
and contains a Mg2+ coordination site on its surface in a 
motif termed a metal ion-dependent adhesion site 
(MIDAS; see Fig. 3). The structure that the I domain 
adopts is present in a wide variety of intracellular 
enzymes, and the crevice at the top of the p sheet forms a 
ligand-binding site, which often includes a metal ion, in 
all known proteins of this class. One of the six Mg2+ 
coordination positions is free to bind ligand; in the crystal 
it adventitiously ligates a glutamic acid residue from a 
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Fig. 2. Structure of VCAM-1 domains 
l-2 based on crystallographic data. (a) 
Schematic representation of the mole- 
cule, with the amino-terminal part of 
the C-D loop (residues 37-43) high- 
lighted in yellow. (b) Atomic structure of 
residues 37-43. The structure is stabi- 
lized by three internal hydrogen bonds 
(shown in yellow), including one that is 
found in a p-turn. Arrows indicate the 
direction of the polypeptide. Figure 
reproduced by kind permission of 
Osborn and colleagues [41. 
neighbouring I domain in the lattice. The importance of 
the M$+ coordination site within the I domain is 
demonstrated by the fact that disruption of the residues 
involved in metal coordination in the I domain affect not 
only M$’ ion binding, but also ligand binding for both 
pz and p1 integrins (when their 01 subunits contain I 
domains) [l l-15l.A direct role for this M2+-binding site 
in integrin binding is strongly suggested by the extra, 
‘available’ coordination site revealed in the crystal struc- 
ture. It is tempting to speculate that the sixth coordinat- 
ing residue is contributed by an acidic aspartate or 
glutamate residue from the interacting IgSF domain. 
Recent mutagenesis studies on LFA-1 also support a 
central role for the Mg 2’ ion in the I domain in binding 
to ICAM- [16]. Residues responsible for species-specific 
binding of human, but not mouse, LFA-1 to human 
ICAM- were mapped, and found to surround the 
Mg2+-binding site on the I domain, defining a ligand 
binding interface on an integrin. 
The conserved features in the MIDAS motif are the 
sequence Asp-Xaa-Ser-Xaa-Ser within the I domain 
(residues 140-144) and non-contiguous threonine 
(Thr209) and aspartate (Asp242) residues. These form 
direct or indirect coordinations with the Mg2+ ion, and, 
together with water molecules that they bind, fulfa five 
of the six octahedral coordination positions (Fig. 3b). 
Analysis of known I domains suggest that the majority 
possess MIDAS motifs. Not all integrin-lg interactions 
involve an I domain, as demonstrated by or4p1 interaction 
with VCAM-1. However, all l3 subunits do possess an 
Asp-Xaa-Ser-Xaa-Ser motif, and mutagenesis of this 
region in p1 and p3 integrins abolishes their interaction 
with extracellular matrix proteins [17,18]. This motif in 
the p subunit has been proposed to be present in a region 
that folds similarly to the I domain [ll]. When all of this 
information is combined, an attractive model of the inter- 
action between integrins and IgSF members at the mol- 
ecular level emerges. The integrin molecule coordinates 
five of six coordination sites on a metal ion through a 
MIDAS motif in either its I domain or its p subunit, 
while an acidic residue (Asp or Glu), prominently pro- 
truding on a C-D loop from the IgSF molecule, acts to 
coordinate the sixth and final metal ion site. 
There is a strong precedent for conserved amino acid 
motifs that are important for integrin binding to other 
targets. Many integrins bind to extracellular matrix pro- 
teins through either Arg-Gly-Asp or Leu-Asp-Val 
motifs found on the matrix proteins, with binding being 
dependent in both cases on the aspartate residue [2]. 
Thus, similar motifs are important in integrin-matrix 
and integrin-IgSF interactions; both require a MIDAS 
motif on the integrin, a metal ion, and an acidic residue 
on the integrin ligand.All of these interactions, therefore, 
may involve a divalent cation bound to an integrin that 
ligates an acidic residue from the binding partner. 
The presence of the integrin-binding motif is not the 
sole determinant of integrin-binding specificity, 
however, as residues outside this motif are required for 
binding, and exchange of this motif in domain 1 of 
VCAM-1 with that in ICAM- did not alterVCAM-1 
specificity for VLA-4 [6]. Similarly, the region of the 
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integrin that is involved in adhesion may vary slightly 
depending on its l&and. For example, various mono- 
clonal antibodies that bind to different regions of the 
LFA-1 I-domain differ in their ability to affect LFA-1 
binding to ICAM-1, -2, or -3 [19,20]. Lastly, not all 
IgSF-integrin interactions are dependent on the inte- 
grin-binding motif described above, as the Mac-l 
binding site on ICAM-1, the third Ig domain [9], con- 
tains no integrin-binding consensus sequence. While 
mutagenesis of ICAM- has revealed that several acidic 
residues in the third Ig domain, including an aspartate 
residue in the C-D loop, are crucial for Mac-l binding, 
the glycosylation state of ICAM- is also important, as 
mutations that destroy sites for N-linked glycosylation 
and agents that interfere with carbohydrate processing 
result in increased Mac-l binding [9]. 
Adhesive interactions vary in requirement for divalent 
cations. Those involving heterophilic binding of one 
IgSF member to another IgSF member, or homophilic 
IgSF interactions, do not require divalent cations for 
binding activity, whereas both the selectin and cadherin 
Fig. 3. Structure of the Mac-l I domain. 
(a) Schematic stereo representation of the 
I domain, with the coordinated Mg*+ ion 
shown in blue. (b) Close-up of the 
MIDAS site. Coordinating oxygen atoms 
are shown in red, and hydrogen bonds 
are shown by dashed red lines. Glu314 
from another I domain molecule is shown 
in gold (E314). The protein backbone is 
shown schematically as a gray ribbon. 
Figure reproduced by kind permission of 
Lee eta/. [l I]. 
families of adhesion molecules require calcium ions. The 
recent crystallization of a cadherin suggests that the Ca2+ 
ions are important not in the ligand interface, but in the 
interface between different domains of the same protein, 
providing rigidity to an adhesion ‘zipper’ [21]. The sepa- 
rate crystallization of regions important in ligand binding 
in an IgSF molecule and an integrin has offered insight 
into how members of these two families might mediate 
adhesive interactions, and has suggested that cations are 
important in this process. However, on exact understand- 
ing of how IgSF members interact with integrins awaits 
the crystal structure of appropriate integrin: IgSF or I 
domain: IgSF co-complexes. 
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